Kikuchi, Japan

Ryoichi Kawamura



 

Average Co-Inventor Count = 5.9

ph-index = 1

Forward Citations = 105(Granted Patents)


Company Filing History:


Years Active: 2012-2022

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):

Title: Ryoichi Kawamura: Innovator in Hemostatic Materials

Introduction

Ryoichi Kawamura is a notable inventor based in Kikuchi, Japan. He has made significant contributions to the field of medical materials, particularly in the development of hemostatic products. With a total of seven patents to his name, Kawamura's work has the potential to impact medical practices significantly.

Latest Patents

One of Kawamura's latest patents involves a formed sheet product and hemostatic material. This innovation consists of a polymer composition that includes at least one protein, such as fibrinogen and thrombin, combined with a polymer from the aliphatic polyester and water-soluble polymer groups. The patent also describes a laminated formed sheet product that features a first polymer composition layer made of fibrinogen and a water-soluble polymer, alongside a second layer composed of thrombin and an aliphatic polyester. These formed products are designed to be applied to wound sites, functioning effectively as hemostatic materials.

Career Highlights

Throughout his career, Ryoichi Kawamura has worked with reputable organizations, including the Chemo-sero-therapeutic Research Institute and Teijin Limited. His experience in these institutions has allowed him to refine his expertise in the development of innovative medical materials.

Collaborations

Kawamura has collaborated with notable colleagues, including Takayuki Imamura and Masaki Hirashima. These partnerships have likely contributed to the advancement of his research and the successful development of his patented products.

Conclusion

Ryoichi Kawamura's contributions to the field of hemostatic materials demonstrate his innovative spirit and dedication to improving medical technology. His patents reflect a commitment to enhancing patient care through advanced materials.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…